Gem Pharma Systems India Private Limited
About Gem Pharma Systems India Private Limited
Data last updated:
Gem Pharma Systems India Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85300MH2019PTC333267. Its GSTIN is 27AAICG0849E1ZN (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Jayakumar Sridharan and Deepak Jayakumar Nair.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 24 26 27/32 Kt Steel Ambernath Indsutrial Area Ambernath (W), Thane, Maharashtra, India – 421501.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.28 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹22.27 Lakh (net margin 5.2%) and EBITDA of ₹23.25 Lakh (EBITDA margin 5.4%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 24 26 27/32 Kt Steel Ambernath Indsutrial Area Ambernath (W), Thane, Maharashtra, India – 421501
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gem Pharma Systems India Private Limited
The main business activity of Gem Pharma Systems India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gem Pharma Systems India Private Limited FY 2025 filings available
Gem Pharma Systems India Private Limited reported revenue of ₹4.28 Cr (up 186% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Gem Pharma Systems India Private Limited
Revenue rose 186% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 9%. EBITDA rose 185% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gem Pharma Systems India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹23.25 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹22.27 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gem Pharma Systems India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gem Pharma Systems India are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Gem Pharma Systems India Private Limited
Gem Pharma Systems India Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunil Great (Hosiery Yarn and Kapadia) Processors Pvt Ltd | ₹4.29 Cr (FY 2024) | •••• | •••• | -30.0% | •••• | Maharastra, Maharashtra, India |
| Sumar Fertilizers Private Limited | ₹4.29 Cr (FY 2019) | •••• | •••• | 98.0% | •••• | Jaipur, Rajasthan, India |
| Prescott Pharmgel Private Limited | ₹4.28 Cr (FY 2025) | •••• | •••• | 101.0% | •••• | Baraut, Uttar Pradesh, India |
| Bhanger Insecticides Private Limited | ₹4.28 Cr (FY 2024) | •••• | •••• | -63.0% | •••• | Chandigarh, India |
| Atharva Nature Healthcare Private Limited | ₹4.28 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Pune, Maharashtra, India |
| Gem Pharma Systems India Private Limited this company | ₹4.28 Cr (FY 2025) | •••• | •••• | 186.0% | •••• | Thane, Maharashtra, India |
| Bael Health Private Limited | ₹4.28 Cr (FY 2025) | •••• | •••• | 243.0% | •••• | Mumbai, Maharashtra, India |
| Anmmol Processors Private Limited | ₹4.28 Cr (FY 2024) | •••• | •••• | -1.0% | •••• | Udaipur, Rajasthan, India |
| Braj Inorganics Private Limited | ₹4.28 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Amravati, Maharashtra, India |
| Sunchem Aromatics Private Limited | ₹4.27 Cr (FY 2025) | •••• | •••• | 156.0% | •••• | Panchkula, Haryana, India |
| Packwell Technologies Private Limited | ₹4.27 Cr (FY 2025) | •••• | •••• | 320.0% | •••• | Dombivali, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Gem Pharma Systems India by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Gem Pharma Systems India Private Limited
Gem Pharma Systems India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayakumar Sridharan Also directs: Gemtech Process Solution LLP | Director | 19 Nov 2019 | 6 Years 10 Months | Current |
| Deepak Jayakumar Nair Also directs: Gemtech Process Solution LLP | Director | 19 Nov 2019 | 6 Years 10 Months | Current |
Ownership and Shareholding of Gem Pharma Systems India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gem Pharma Systems India Private Limited
Gem Pharma Systems India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Gem Pharma Systems India Private Limited
Employment history and EPFO contributions of people linked to Gem Pharma Systems India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gem Pharma Systems India Private Limited
Gem Pharma Systems India Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Deepak Jayakumar Nair was appointed as Director on 19 Nov 2019.
Credit Ratings, Litigation & Regulatory Alerts for Gem Pharma Systems India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gem Pharma Systems India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gem Pharma Systems India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gem Pharma Systems India Private Limited
Gem Pharma Systems India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICG0849E1ZN | Maharashtra | Active | 19 Mar 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gem Pharma Systems India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gem Pharma Systems India Private Limited
Gem Pharma Systems India is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 November 2019 (7+ years old) and is registered under CIN U85300MH2019PTC333267.
Gem Pharma Systems India reported revenue of ₹4.28 Cr for FY 2025 (up 186% YoY).
Gem Pharma Systems India has 2 current directors:
- Jayakumar Sridharan - Director
- Deepak Jayakumar Nair - Director
Gem Pharma Systems India reported a net profit of ₹22.27 Lakh (net margin 5.2%) and EBITDA of ₹23.25 Lakh (EBITDA margin 5.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gem Pharma Systems India is -9% over three years. In the latest year (FY 2025) revenue rose 186%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gem Pharma Systems India is 27AAICG0849E1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Gem Pharma Systems India is U85300MH2019PTC333267. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gem Pharma Systems India was incorporated on 19 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Gem Pharma Systems India by revenue are Sunil Great (Hosiery Yarn and Kapadia) Processors Pvt Ltd, Sumar Fertilizers Private Limited, Prescott Pharmgel Private Limited, Bhanger Insecticides Private Limited, Atharva Nature Healthcare Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Deepak Jayakumar Nair was appointed as Director on 19 Nov 2019. Jayakumar Sridharan was appointed as Director on 19 Nov 2019.
The registered office of Gem Pharma Systems India is at Plot No. 24 26 2732 Kt Steel Ambernath Indsutrial Area Ambernath W, Thane, Maharashtra, India – 421501.